Paper Details

  1. Home
  2. Paper Details

Is a 9-month treatment sufficient in tuberculous enterocolitis? A prospective, randomized, single-centre study.

Author: JungH C, KimJ S, KimS G, SongI S

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study examines the duration of anti-tuberculous therapy needed for intestinal tuberculosis, which has become more prevalent in the context of the AIDS epidemic and immunosuppressive therapy use.
Paper Details　
Original Abstract of the Article :
Tuberculosis has increased in parallel with the acquired immunodeficiency syndrome epidemic and the use of immunosuppressive therapy, and the growing incidence of extra-pulmonary tuberculosis, especially with intestinal involvement, reflects this trend. However, the duration of anti-tuberculous ther...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1046/j.1365-2036.2003.01599.x

データ提供：米国国立医学図書館（NLM）

Tuberculous Enterocolitis: Navigating the Desert of Treatment

This research investigates the optimal duration of anti-tuberculous therapy for tuberculous enterocolitis, a condition that can be as complex and persistent as a desert sandstorm. It’s like finding a new and more effective way to combat a formidable foe in the harsh landscape of disease. The study explores the effectiveness of a 9-month treatment regimen in patients with tuberculous enterocolitis. This is like testing a new strategy for navigating the treacherous terrain of a disease. The study concludes that a 9-month treatment regimen may be sufficient for some patients with tuberculous enterocolitis. This is like finding a more efficient way to combat a disease, allowing for a more manageable and potentially less burdensome treatment journey.

New Insights into Tuberculosis Treatment

This research sheds new light on the treatment of tuberculous enterocolitis. It’s like finding a new and more efficient way to manage a complex and challenging disease. By investigating the optimal duration of therapy, we can potentially reduce the burden of treatment for patients and enhance their chances of a full recovery.

Living Well with Tuberculosis

If you have tuberculosis, it's important to work closely with your doctor to develop a treatment plan that's right for you. This is like finding a guide to help you navigate the challenges of your condition and find the resources that can help you thrive. By adhering to your treatment plan and monitoring your progress, you can increase your chances of a full recovery and improve your quality of life.

Dr.Camel's Conclusion

This research highlights the importance of continuing to explore and refine our understanding of tuberculosis. It’s like finding new and more effective ways to combat this disease in the vast and challenging landscape of human health. By conducting rigorous research and developing innovative treatment strategies, we can improve the lives of patients and work towards a world free from the burden of tuberculosis.

Date :
  1. Date Completed 2003-10-09
  2. Date Revised 2019-09-01
Further Info :

Pubmed ID

12848629

DOI: Digital Object Identifier

10.1046/j.1365-2036.2003.01599.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.